MedTrace Logo

Morehouse Total Cancer Care Protocol

NCT04804878 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2021-03-18

No results posted yet for this study

Summary

The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinical trials, and "personalized medicine" for our community oncology partners (i.e., community hospital systems, and other cancer care providers). To bring new translational research to the community, Morehouse School of Medicine has initiated the Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of African American cancer patients, survivors, or those at risk of having cancer. This is not a treatment trial, but a longitudinal study designed to create a centralized cancer biorepository for precision medicine.

Conditions

Interventions

PROCEDURE

Collection of blood, tissue, and other biological samples.

Behavioral health assessments, including quality of life.

OTHER

Medical Chart Review

Health data abstracted directly from patient's health records

Sponsors & Collaborators

  • Morehouse School of Medicine

    lead OTHER

Principal Investigators

  • James W Lillard, PhD · Morehouse School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-05
Primary Completion
2035-04-30
Completion
2037-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04804878 on ClinicalTrials.gov